Bailard’s Innophos Holdings, Inc. IPHS Stock Holding History

Bailard’s Portfolio IPHS Stock Details IPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,700	Closed	-$780K	–	522
2017 Q4	$780K	Buy	+16,700	New	+$780K	0.05%	261

Other funds holding IPHS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bailard's IPHS Position: Q1 2018 in Review

Bailard sold out of Innophos Holdings, Inc. (IPHS) in Q1 2018, closing a stake of 16,700 shares — an estimated $780K sold.

Bailard first reported a position in IPHS in Q4 2017 and held it in 1 quarter. The position peaked at $780K in Q4 2017. 167 funds tracked by Wall St. Rank hold IPHS as of Q1 2018.

Bailard reported no remaining Innophos Holdings, Inc. position as of Q1 2018 after selling out during the quarter.
Bailard sold 16,700 Innophos Holdings, Inc. shares in Q1 2018, an estimated $780K.
Bailard first reported a position in Innophos Holdings, Inc. in Q4 2017 and held it in 1 quarter.
Bailard's Innophos Holdings, Inc. position peaked at $780K in Q4 2017.
167 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2018.

Based on Bailard's 13F filing for Q1 2018, filed 7 May 2018.